行情

OGEN

OGEN

ORAGENICS
AMEX

实时行情|Nasdaq Last Sale

1.070
-0.060
-5.31%
盘前: 1.080 +0.01 +0.93% 08:05 08/07 EDT
开盘
1.100
昨收
1.130
最高
1.110
最低
1.060
成交量
300.02万
成交额
--
52周最高
2.090
52周最低
0.3500
市值
6,516.32万
市盈率(TTM)
-2.8322
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测OGEN价格均价为2.500,最高价位2.500,最低价为2.500。

EPS

OGEN 新闻

更多
Ocugen and vTv Therapeutics among healthcare gainers; Vaxart leads the losers
Seeking Alpha · 07/27 15:02
INTC, NIO among premarket losers
Seeking Alpha - Article · 07/24 12:24
Mid-Afternoon Market Update: Gold Rises 1%; Verb Technology Shares Plummet
Toward the end of trading Wednesday, the Dow traded up 0.31% to 26923.91 while the NASDAQ fell 0.09% to 10670.29. The S&P also rose, gaining 0.26% to 3,265.71.
Benzinga · 07/22 18:48
Oragenics rallies on encouraging data supporting potential COVID-19 vaccine
Nano cap Oragenics (NYSEMKT:OGEN) jumps 36% premarket on robust volume in reaction to its announcement that its in-licensed SARS-CoV-2 spike protein genera
seekingalpha · 07/22 18:19
Oragenics rallies on encouraging data supporting potential COVID-19 vaccine
Seeking Alpha - Article · 07/22 13:19
Organics shares are trading higher after the company said its preclinical study showed that the SARS-CoV-2 spike protein licensed by the company from NIH produces neutralizing antibodies.
Benzinga · 07/22 12:54
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed by Oragenics from the NIH Produces Neutralizing Antibodies
Business Wire · 07/22 12:30
NAK, EXK among premarket gainers
Seeking Alpha - Article · 07/22 12:16

所属板块

生物技术和医学研究
-0.96%
制药与医学研究
-0.46%

热门股票

代码
价格
涨跌幅

OGEN 简况

Oragenics, Inc. is a healthcare company. The Company is focused on developing treatments for oral mucositis and novel antibiotics against infectious disease. The Company is focused on developing of the TerraCoV2 immunization product candidate. The Company’s product candidate includes, OG716, as an antibiotic, as well as other homolog antibiotic product candidates and AG013 for the treatment of oral mucositis in patients undergoing treatment for cancer. The Company have developed other product such as weight loss candidate, LPT3-04 and SMaRT Replacement Therapy.
展开

微牛提供Oragenics Inc(AMEX-OGEN)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的OGEN股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易OGEN股票基本功能。